UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-04, Vol.385 (9978), p.1653-1661

2015

Volltextzugriff (PDF)

Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study

Therapeutic advances in hematology, 2023-01, Vol.14, p.20406207231166779-20406207231166779

2023

Volltextzugriff (PDF)

Thrombosis and thrombocytopenia after HPV vaccination

Journal of thrombosis and haemostasis, 2022-03, Vol.20 (3), p.700-704

2022

Volltextzugriff (PDF)

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

The Lancet (British edition), 2012, Vol.379 (9810), p.31-38

2012

Volltextzugriff (PDF)

Long‐term outcomes of patients treated with rituximab as second‐line treatment for adult immune thrombocytopenia – Follow‐up of the RITP study

British journal of haematology, 2020-11, Vol.191 (3), p.460-465

2020

Volltextzugriff (PDF)

Surgical outcomes in patients with haemophilia A or B receiving extended half‐life recombinant factor VIII and IX Fc fusion proteins: Real‐world experience in the Nordic countries

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-09, Vol.28 (5), p.713-719

2022

Volltextzugriff (PDF)

Bone mineral density in haemophilia – a multicentre study evaluating the impact of different replacement regimens

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-03, Vol.28 (2), p.239-246

2022

Volltextzugriff (PDF)

Comparison of free‐living physical activity measurements between ActiGraph GT3X‐BT and Fitbit Charge 3 in young people with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-11, Vol.28 (6), p.e172-e180

2022

Volltextzugriff (PDF)

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial

The Lancet. Haematology, 2016-02, Vol.3 (2), p.e64-e71

2016

Volltextzugriff (PDF)

Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-03, Vol.29 (2), p.658-667

2023

Volltextzugriff (PDF)

Factors associated with physical activity in young people with haemophilia A on prophylaxis

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-05, Vol.29 (3), p.900-909

2023

Volltextzugriff (PDF)

No difference in quality of life between persons with severe haemophilia A and B

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-07, Vol.29 (4), p.987-996

2023

Volltextzugriff (PDF)

Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology

Platelets (Edinburgh), 2022-05, Vol.33 (4), p.640-644

2022

Volltextzugriff (PDF)

Once‐weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8‐GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-05, Vol.25 (3), p.373-381

2019

Volltextzugriff (PDF)

Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series

Frontiers in neurology, 2021-07, Vol.12

2021

Volltextzugriff (PDF)

Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B‐NORD study

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.366-374

2021

Volltextzugriff (PDF)

Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management

Laryngoscope investigative otolaryngology, 2024-02, Vol.9 (1), p.e1196-n/a

2024

Volltextzugriff (PDF)

Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-03, Vol.25 (2), p.334-342

2019

Volltextzugriff (PDF)

Haemophilic arthropathy: Long-term outcomes in 107 primary total knee arthroplasties

The knee, 2014-01, Vol.21 (1), p.147-150

2014

Volltextzugriff (PDF)

Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors—An In Vitro Study

Clinical and applied thrombosis/hemostasis, 2021, Vol.27, p.107602962110211-10760296211021156

2021

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency

Hematology (Luxembourg), 2020-01, Vol.25 (1), p.17-25

2020

Volltextzugriff (PDF)

Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis-the CaVenT Study: Rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)

The American heart journal, 2007-11, Vol.154 (5), p.808-814

2007

Volltextzugriff (PDF)

The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis

Platelets (Edinburgh), 2020-01, Vol.31 (1), p.43-47

2020

Volltextzugriff (PDF)

Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events

Clinical and applied thrombosis/hemostasis, 2022-01, Vol.28, p.10760296221141893-10760296221141893

2022

Volltextzugriff (PDF)

Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects

Vaccines (Basel), 2022-08, Vol.10 (8), p.1267

2022

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial

Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study

Thrombosis and thrombocytopenia after HPV vaccination

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

Long‐term outcomes of patients treated with rituximab as second‐line treatment for adult immune thrombocytopenia – Follow‐up of the RITP study

Surgical outcomes in patients with haemophilia A or B receiving extended half‐life recombinant factor VIII and IX Fc fusion proteins: Real‐world experience in the Nordic countries

Bone mineral density in haemophilia – a multicentre study evaluating the impact of different replacement regimens

Comparison of free‐living physical activity measurements between ActiGraph GT3X‐BT and Fitbit Charge 3 in young people with haemophilia

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial

Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers

Factors associated with physical activity in young people with haemophilia A on prophylaxis

No difference in quality of life between persons with severe haemophilia A and B

Anti-PF4/polyanion antibodies in COVID-19 patients are associated with disease severity and pulmonary pathology

Once‐weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8‐GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)

Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series

Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B‐NORD study

Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management

Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study

Haemophilic arthropathy: Long-term outcomes in 107 primary total knee arthroplasties

Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors—An In Vitro Study

Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency

Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis-the CaVenT Study: Rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771)

The impact of rivaroxaban on primary hemostasis in patients with venous thrombosis

Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events

Elevated NETs and Calprotectin Levels after ChAdOx1 nCoV-19 Vaccination Correlate with the Severity of Side Effects

Suchergebnisse filtern